Blood And Tissue Screening Tests Top Australia’s IVD Regulatory Scheme
This article was originally published in The Gray Sheet
In vitro diagnostics that screen for pathogens in the blood supply or in organ and tissue donations would be regulated as highest-risk Class IV devices under the regulatory framework for IVDs proposed by Australia's Therapeutic Goods Administration (TGA)
You may also be interested in...
Australia's proposed regulatory structure for in vitro diagnostic devices would bring new regulatory requirements and costs for a number of products that currently are exempt from oversight
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.